7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Correction to: LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway

      correction

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Correction to: J Exp Clin Cancer Res https://doi.org/10.1186/s13046-018-0994-x In the publication of this article [1], there is an error in Fig. 5 c (panel 4, group of InmiR-26a + silinc01296 in SW620). The revised Fig. 5 which includes 5C has now been included in this correction. Fig. 5 The effect of co-expression linc01296 and miR-26a on CRC progression. a Flow cytometry showed O-linked glycosylation level detected by fluorescein isothiocyanate (FITC)-conjugated VVA on the cell surface of transfected CRC cells. b CCK8 assay showed variant growth rate of transfected CRC cells. c Colony formation assay detected proliferative formation with different treated CRC cells. d Aggressiveness changed was determined by transwell assay, the migratory and invasive cells were counted. e CRC cells were treated with 5-FU, and the cell viability was detected by CCK8 assay. f IC50 values of treated CRC cells were calculated. g The effect of 5-FU on CRC cell proliferation was determined by colony formation assay. h Flow cytometry showed the apoptosis rate of transfected CRC cells in response to 5-FU. i FITC-VVA on transfected CRC cells surface was detected by flow cytometry. j The growth curves of transfected CRC cells were pictured after conducting CCK8 assay. k Proliferation of treated CRC cells was examined by colony formation assay. l Migration and invasion were observed in transfected SW620 cells. m With 5-FU treatment, the cell viability was determined by CCK8 assay. n The IC50 values were subsequently calculated. o 5-FU resistant CRC cells were transfected with linc01296 or miR-26a mimic, and the colony formation was counted in response to 5-FU. p The apoptosis rate of transfected CRC cells was detected after 5-FU treatment by flow cytometry. The data were means ± SD of three independent assays (*P < 0.05)

          Related collections

          Author and article information

          Contributors
          jiali0386@sina.com
          Journal
          J Exp Clin Cancer Res
          J. Exp. Clin. Cancer Res
          Journal of Experimental & Clinical Cancer Research : CR
          BioMed Central (London )
          0392-9078
          1756-9966
          21 August 2019
          21 August 2019
          2019
          : 38
          : 367
          Affiliations
          [1 ]ISNI 0000 0000 9558 1426, GRID grid.411971.b, College of Laboratory Medicine, , Dalian Medical University, ; 9 Lushunnan Road Xiduan, Dalian, 116044 Liaoning Province China
          [2 ]GRID grid.452828.1, Department of General Surgery, , the Second Affiliated Hospital of Dalian Medical University, ; Dalian, 116027 Liaoning Province China
          Article
          1367
          10.1186/s13046-019-1367-9
          6702711
          31431194
          298a3352-df90-482f-9b96-f6fd4a128821
          © The Author(s). 2019

          Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

          History
          Categories
          Correction
          Custom metadata
          © The Author(s) 2019

          Oncology & Radiotherapy
          Oncology & Radiotherapy

          Comments

          Comment on this article